Iran First Asian State to Achieve Technology of Producing Drug Nanocarriers

“The issue of encapsulating drugs to increase the effectiveness and reduce drug toxicity has been raised for years. Our device is designed with exactly this goal in mind, to be able to place the drug inside appropriate carriers and increase its effectiveness while simultaneously reducing the dose,” said Mohammad Javad Javid, a sales expert at Rizsamaneh Behboud Darman company stationed at the Health Park of Mashhad University of Medical Sciences.

He explained that by using this device, the process of designing and preparing drug nanocarriers on a laboratory and industrial scale can be carried out simply and efficiently, adding, “This technology can meet a significant part of the country's needs for production of drug nanocarriers in the future, specially in the treatment of diseases like cancer and other areas.”

“Our manufactured product has reached the commercialization stage and has received all the necessary licenses. At present, the foreign model of this device is only made by a Canadian company, and its price is several times higher than our Iranian model,” Javid said.

Microfluidic technologies have revolutionized the synthesis of nanocarriers for drug and gene delivery, providing unparalleled precision and efficiency in the production of therapeutic nanoparticles.

By enabling the controlled production of nanocarriers with customizable size, composition, and release profiles, microfluidic platforms have represented a powerful tool in improving therapeutic efficacy and targeting capabilities. Key innovations discussed include the use of droplet microfluidics, flow-focusing techniques, and the incorporation of stimuli-responsive materials.

4155/v